SCHEMBL21484913

SCHEMBL21484913

N#C/C(=C\c1cc(Cl)c(O)c(Cl)c1)C(=O)Nc1nc(-c2ccccn2)cs1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 8/20 0.52
LMNA P02545 3/20 0.49
MAPT P10636 3/20 0.49
HTT P42858 2/20 0.49
TDP1 Q9NUW8 2/20 0.49
HSP90AA1 P07900 1/20 0.49
GAA P10253 1/20 0.49
KMT2A Q03164 1/20 0.49
KDM4A O75164 1/20 0.49
KDM4B O94953 1/20 0.49
KDM5B Q9UGL1 1/20 0.49
L3MBTL1 Q9Y468 3/20 0.48
ALDH1A1 P00352 3/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
KDM4E B2RXH2 1/20 0.48
ALOX15 P16050 1/20 0.48
SLC2A1 P11166 1/20 0.48
RAB9A P51151 3/20 0.47
NPC1 O15118 1/20 0.47
MRE11 P49959 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21505934 0.89 ADORA3 (0.50) ADORA3LMNAMAPTHTTTDP1
SCHEMBL21505933 0.89 SLC2A1 (0.53) ADORA3LMNAMAPTHTTTDP1
SCHEMBL21484775 0.87 MRE11 (0.51) ADORA3LMNAMAPTKMT2AALDH1A1
SCHEMBL21484670 0.86 MRE11 (0.61) ADORA3LMNAMAPTHTTTDP1
SCHEMBL21484598 0.86 MRE11 (0.57) ADORA3LMNAMAPTTDP1GAA
SCHEMBL21505948 0.85 FTO (0.43) LMNAMAPTHTTGAAKMT2A
SCHEMBL21484620 0.84 MRE11 (0.60) LMNAMAPTGAAKMT2AALDH1A1
SCHEMBL21484918 0.82 GSTO1 (0.49) LMNAMAPTHTTKMT2AALDH1A1
SCHEMBL21484921 0.82 MRE11 (0.47) LMNAMAPTHTTGAAKMT2A
SCHEMBL21484719 0.81 MRE11 (0.59) LMNAMAPTKMT2AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11584742-B2 Substituted aminothiazoles as inhibitors of nucleases MASARYKOVA UNIVERZITA (CZ) 2023-02-21 US disclosed
US-11584742-B2 Substituted aminothiazoles as inhibitors of nucleases MASARYKOVA UNIVERZITA (CZ) 2023-02-21 US disclosed
US-20220002282-A1 SUBSTITUTED AMINOTHIAZOLES AS INHIBITORS OF NUCLEASES MASARYKOVA UNIVERZITA (CZ) 2022-01-06 US disclosed
US-20220002282-A1 SUBSTITUTED AMINOTHIAZOLES AS INHIBITORS OF NUCLEASES MASARYKOVA UNIVERZITA (CZ) 2022-01-06 US disclosed
EP-3556755-B1 SUBSTITUTED AMINOTHIAZOLES AS INHIBITORS OF NUCLEASES UNIV MASARYKOVA (CZ) 2021-11-17 EP disclosed
EP-3556755-B1 SUBSTITUTED AMINOTHIAZOLES AS INHIBITORS OF NUCLEASES UNIV MASARYKOVA (CZ) 2021-11-17 EP disclosed
CN-112313229-A Substituted aminothiazoles as inhibitors of nucleases 马萨里克大学 2021-02-02 CN disclosed
WO-2019201865-A1 SUBSTITUTED AMINOTHIAZOLES AS INHIBITORS OF NUCLEASES MASARYKOVA UNIVERZITA (CZ) 2019-10-24 WO disclosed
EP-3556755-A1 SUBSTITUTED AMINOTHIAZOLES AS INHIBITORS OF NUCLEASES Masarykova univerzita (CZ) 2019-10-23 EP disclosed
EP-3556755-A1 SUBSTITUTED AMINOTHIAZOLES AS INHIBITORS OF NUCLEASES Masarykova univerzita (CZ) 2019-10-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11584742-B2 Substituted aminothiazoles as inhibitors of nucleases RNASEH1, DNASE1, FEN1 ADORA3 1009/4885LMNA 522/4885MAPT 706/4885
US-20220002282-A1 SUBSTITUTED AMINOTHIAZOLES AS INHIBITORS OF NUCLEASES RNASEH1, DNASE1, FEN1 ADORA3 1009/4885LMNA 522/4885MAPT 706/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.